94 related articles for article (PubMed ID: 7848690)
1. [Immunologic changes in chronic post-transfusion positive hepatitis C and non-A non-B non-C hepatitis].
Nocito M; Erdozain JC; Martín-de-Arguila C; Chi Anderson T; Gil Grande LA; Brieva JA; Barcena R
Rev Esp Enferm Dig; 1994 Nov; 86(5):803-7. PubMed ID: 7848690
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
3. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.
Fournillier A; Freida D; Defrance T; Merle P; Trépo C; Inchauspé G
J Med Virol; 2004 Apr; 72(4):566-74. PubMed ID: 14981759
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
7. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
9. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.
Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
11. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
12. Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction.
Reece AS
Addict Biol; 2009 Apr; 14(2):214-26. PubMed ID: 18811680
[TBL] [Abstract][Full Text] [Related]
13. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
16. Serum beta 2-microglobulin levels in chronic post-transfusion non A non B liver disease.
Pirotte J; Borlée-Hermans G; Boniver J; Godon JP
Biomed Pharmacother; 1988; 42(1):55-9. PubMed ID: 3136811
[TBL] [Abstract][Full Text] [Related]
17. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of immunoglobulins in non-A/non-B hepatitis--a contribution to prognostic evaluation].
Wiese M; Brunner HP; Kretzschmar F
Z Gesamte Inn Med; 1985 Apr; 40(8):242-4. PubMed ID: 3925653
[TBL] [Abstract][Full Text] [Related]
19. Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C.
Yamashiki M; Nishimura A; Suzuki H; Sakaguchi S; Kosaka Y
Hepatology; 1997 Jun; 25(6):1390-7. PubMed ID: 9185758
[TBL] [Abstract][Full Text] [Related]
20. Immunological abnormalities in acute post-transfusion hepatitis non-A non-B.
Salillas P; Bárcena R; Nocito M; Erdozain JC; Botella A; Brieva JA
Liver; 1991 Jun; 11(3):170-5. PubMed ID: 1909413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
